Delivery Order SPE2DB20D3505-SPE2DB25FU2R8
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication, with a ceiling value of $6,014.13 and a performance period ending on March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $5,666.28 and a completion date of January 8, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award SPE2DB20D2104|SPE2DB25F1268, with a ceiling value of $3,683.69, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication, to support military healthcare programs. It is a firm-fixed-price delivery order contract with a period of performance through November 4, 2024. AmerisourceBergen, a major pharmaceutical distributor,...
This federal contract award, valued at $4,504.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with an ultimate completion date of December 4, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,243.97 firm-fixed-price delivery order is for the supply of 4,567,058,750 units of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $7,607.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with an ultimate completion date of November 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FREB3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,639.37 firm-fixed-price delivery order contract is for the supply of Candesartan Cilexetil 16 mg tablets. The contract is not designated as a set-aside. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $4,264.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract has an ultimate completion date of December 20, 2024. This contract is not designated as a set-aside and is for open competition. AmerisourceBergen, as the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.19 delivery order is for Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of October 28, 2024 and utilizes a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery...
The federal contract award detailed is for the delivery of 90-count tablets of Candesartan Cilexetil 32 mg, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,281.64 and an ultimate completion date of January 31, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999...